Immune reconstitution in HIV-1 infected patients treated for two years with highly active antiretroviral therapy

被引:0
作者
Almeida, R. A. M. B.
Souza, L. R.
Calvi, S. A.
Ikoma, M. R., V
Silva, V. A.
Curi, P. R.
Meira, D. A.
机构
[1] Univ Estadual Paulista, Dept Trop Dis & Imaging Diagnosis, Botucatu Sch Med, BR-18618000 Sao Paulo, Brazil
[2] Univ Estadual Paulista, Botucatu Sch Med, Appl Immunol Lab Trop Dis, Sao Paulo, Brazil
[3] Botucatu Hemoctr Botucatu, Sao Paulo, Brazil
[4] Univ Estadual Paulista, Botucatu Sch Vet Med & Anim Husbandry, Sao Paulo, Brazil
关键词
HIV; immune reconstitution; antiretroviral; HAART; cytokines; CD(45)RA; CD45RO;
D O I
暂无
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
The aim of this paper was to evaluate the immune reconstitution of HIV-1 patients subjected to highly active antiretroviral therapy (HAART) for two years or more according to CD(45)RA and CD45RO cell count; determination of IL-2, IFN-gamma, IL-4, IL-10 and TNF-alpha serum levels; CD4+ T and CD8+ T lymphocyte count; and plasma viral load (VL) determination. For this purpose, a cross sectional study was carried out in the Tropical Diseases Area, Botucatu School of Medicine, Sao Paulo State University, UNESP, Botucatu, Sao Paulo, Brazil. Between June 2001 and April 2002, 37 HIV-1 infected patients were evaluated, 13 with treatment indication but untreated (G1), 9 subjected to HAART for 5-7 months (G2), and 15 treated for two years or more (G3); both treated groups used medication regularly and without failure. Forty-nine normal individuals were studied as controls (GC-1 and GC-2). There was a tendency (p < 0.10) for the predominance of two nucleoside reverse transcriptase inhibitors (NRTI) associated with one non-nucleoside reverse transcriptase inhibitor (NNRTI) regimen in G2; and two NRTI associated with a protease inhibitor (PI) in G3. Statistical differences between groups were seen for CD(45)RA (G1 <[G3= GC-2]; p < 0.05) and CD45RO (G1 < GC-2 < G3; p < 0.01) cells, and CD4+ T lymphocyte count (G1 < G3; G2-intermediate; p < 0.05), VL determination (G1 >[G2=G3]; p < 0.001), TNF-alpha serum determination ([G1 > G3; G2=intermediate]> GC-1; p < 0.001), IL-2 (G1 <[G2=G3= GC-1]; p < 0.01), IFN-gamma ([G1= GC1]<[ GC-2= G3]; p < 0.001), IL-4 and IL-10 ([G1=G2=G3]> GC-1; p < 0.001), serum cytokine profiles, with a higher proportion of subtype 2 in G1 and mature subtype 0 in G2 and G3 (p < 0.005). There was no statistical difference for CD8+ T lymphocyte counts (G1= G2= G3; p < 0.50). Consistency was seen between positive correlations of profile 1 definer cytokines (IL-2 and IFN-gamma), CD(45)RA and CD45RO cells, and CD4+ T lymphocyte counts and between positive correlations of profile 2 definer cytokines (IL-4 and IL-10) with TNF-alpha, and VL. The negative correlations were also consistent as they expressed the inverse of the positives. The variables with the highest number of correlations were IL-2, IFN-gamma, and VL, followed by CD(45)RA and CD45RO cells, and IL-10. The variables with the lowest number of correlations were CD4+ T and CD8+ T lymphocytes. The results express the partial but important immune reconstitution in HIV- 1 infected individuals with the interference of HAART and the importance of cytokines especially IL-2 and IFN-gamma,and CD(45)RA and CD45RO cells as surrogate markers of this reconstitution.
引用
收藏
页码:91 / 109
页数:19
相关论文
共 30 条
[1]  
ALFANO M, 2001, CELLULAR ASPECTS HIV, P293
[2]   Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy:: Persistent TNF activation is associated with virologic and immunologic treatment failure [J].
Aukrust, P ;
Müller, F ;
Lien, E ;
Nordoy, I ;
Liabakk, NB ;
Kvale, D ;
Espevik, T ;
Froland, SS .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (01) :74-82
[3]   Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease [J].
Autran, B ;
Carcelain, G ;
Li, TS ;
Blanc, C ;
Mathez, D ;
Tubiana, R ;
Katlama, C ;
Debre, P ;
Leibowitch, J .
SCIENCE, 1997, 277 (5322) :112-116
[4]  
CARCELAIN G, 2001, CELLULAR ASPECTS HIV, P399
[5]   Type 1 and type 2 cytokines in HIV infection - A possible role in apoptosis and disease progression [J].
Clerici, M ;
Fusi, ML ;
Ruzzante, S ;
Piconi, S ;
Biasin, M ;
Arienti, D ;
Trabattoni, D ;
Villa, ML .
ANNALS OF MEDICINE, 1997, 29 (03) :185-188
[6]   THE TH1-TH2 HYPOTHESIS OF HIV-INFECTION - NEW INSIGHTS [J].
CLERICI, M ;
SHEARER, GM .
IMMUNOLOGY TODAY, 1994, 15 (12) :575-581
[7]   A T(H)1-]T(H)2 SWITCH IS A CRITICAL STEP IN THE ETIOLOGY OF HIV-INFECTION [J].
CLERICI, M ;
SHEARER, GM .
IMMUNOLOGY TODAY, 1993, 14 (03) :107-110
[8]   LACK OF EVIDENCE FOR THE DICHOTOMY OF T(H)1 AND T(H)2 PREDOMINANCE IN HIV-INFECTED INDIVIDUALS [J].
GRAZIOSI, C ;
PANTALEO, G ;
GANTT, KR ;
FORTIN, JP ;
DEMAREST, JF ;
COHEN, OJ ;
SEKALY, RP ;
FAUCI, AS .
SCIENCE, 1994, 265 (5169) :248-252
[9]  
GUOGEON ML, 2001, CELLULAR ASPECTS HIV, P249
[10]   Population biology of HIV-1 infection:: Viral and CD4+ T cell demographics and dynamics in lymphatic tissues [J].
Haase, AT .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :625-656